Collaboration Details

Title of Collaborative Activity:

Diabetes Autoantibody Standardization Program (DASP)

Description of Collaborative Activity:

The aim of DASP is to improve the measurements of the autoantibodies predictive of type 1 diabetes, and to decrease laboratory-to-laboratory variation. In combination with genetic screening, autoantibody tests are used to identify individuals at elevated risk of developing type 1 diabetes and to characterize autoimmunity.

Type of Collaborative Activity:

Select Type of Collaborative Activity

Year the Collaborative Activity Originated:

1998

NIH Participating Institutes/Centers/Office of the Director:

NIDDK

HHS Agency Collaborators on this Activity:

CDC